Eugia Pharma Specialities Limited, a active public limited company, was established on 17 April 2013 in Ameerpet, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24297TG2013PLC087048. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹800.00 Cr and a paid-up capital of ₹621.01 Cr.
It upholds a compliant status. Employing 2,763 professional, Its leadership includes Madan Mohan Reddy Mettu (Director), Veerayya Chowdary Kosaraju (Director), Yugandhar Puvvala (Ceo). Past directors included Vinod Kumar Reddy Aerva, Vivek Kaushik, Sanjeev Indravadan Dani. It holds no open charges and ₹724.00 Cr settled loans. Its latest AGM occurred on 08 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.2, Maitrivihar,, Ameerpet, Telangana, 500038.
U24297TG2013PLC087048
087048
17 April 2013
₹800.00 Cr
₹621.01 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Eugia Pharma Specialities Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madan Mohan Reddy Mettu | Director | 17 Apr 2013 | Current |
| Veerayya Chowdary Kosaraju | Director | 01 Dec 2021 | Current |
| Yugandhar Puvvala | Ceo | 01 Oct 2021 | Current |
| Santhanam Subramanian | Director | 01 Oct 2021 | Current |
| Ragunathan Kannan | Director | 01 Dec 2021 | Current |
| Sundari Raviprasad Pisupati | Director | 01 Dec 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Oct 2017 | Past |
| Pramod Abcsdd | Alternate Director | 24 Jan 2018 | Past |
| Pramod Abcsdd | Director | 01 Oct 2021 | Past |
| Pramod Abcsdd | Director | 25 Jun 2015 | Past |
| Pramod Abcsdd | Additional Director | 24 Aug 2015 | Past |
| Pramod Abcsdd | Whole-Time Director | 01 Oct 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eugia Pharma Specialities Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 55.49% increase. The company also saw a substantial improvement in profitability, with a 198.9% increase in profit. The company's net worth Soared by an impressive increase of 68.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Eugia Pharma Specialities had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹7,240,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2019 | Others | ₹105.00 Cr | Satisfied |
| 06 Jul 2017 | Others | ₹500.00 Cr | Satisfied |
| 24 Feb 2014 | Export Import Bank Of India | ₹119.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Eugia Pharma Specialities has a workforce of 2763 employees as of Feb 14, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Eugia Pharma Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eugia Pharma Specialities's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Eugia Pharma Specialities Limited last Annual general meeting of members was held on 08 Sep 2025 as per latest MCA records. was completed.
The activity Eugia Pharma Specialities Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
Progress on Vallamkondu Aravind Kumar was appointed as a Cfo was appointed as a Cfo on 21 Feb 2024 & has been associated with this company since 1 year 9 months . was documented.
A charge registered on 27 Sep 2019 via Charge ID 100295568 with Others was fully satisfied on 04 Mar 2022. was recorded as a recent event.
Progress on Yugandhar Puvvala was appointed as a CEO was appointed as a CEO on 27 Dec 2021 & has been associated with this company since 3 years 11 months . was documented.
Veerayya Chowdary Kosaraju was appointed as a Director was appointed as a Director on 01 Dec 2021 & has been associated with this company since 3 years 11 months . was recorded as a recent event.
The CIN of Eugia Pharma Specialities Limited is U24297TG2013PLC087048.
Eugia Pharma Specialities Limited is headquartered at Plot No.2, Maitrivihar,, Ameerpet, Telangana, 500038.
Eugia Pharma Specialities Limited was incorporated on 17 April 2013.
The current directors of Eugia Pharma Specialities Limited are
The primary industry of Eugia Pharma Specialities Limited is Manufacturing.
Eugia Pharma Specialities Limited is unlisted.
The authorized capital of Eugia Pharma Specialities Limited is ₹800.00 Cr, and the paid-up capital is ₹621.01 Cr.
The compliance status of Eugia Pharma Specialities Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX